BCAX Bicara Therapeutics Inc.

NASDAQ
$9.75

Bicara Therapeutics Inc. (BCAX) Earnings News

Earnings press releases, previews and reviews for Bicara Therapeutics Inc. (BCAX), newest first. Our most recent is review: Bicara Therapeutics Misses as Losses Widen; Enrollment Milestone Overshadowed by a Competitive Reset in Head and Neck Cancer.